MAD-8100

N/A

Report date: 2025/01/26 15:53:49
NME

Base Information

Drug NameMAD-8100
Drug Alias Namesmall molecule therapeutics (Madera)small molecule therapeutics (Madera)MAD-8100
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionATP binding cassette subfamily A member 1 stimulantsApolipoprotein E agonistsBeta amyloid A4 protein inhibitors
TargetsATP binding cassette subfamily A member 1Apolipoprotein EBeta amyloid A4 protein
Therapy Area/IndicationsMacular DegenerationAlzheimer DiseaseBrain Injuries, Traumatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMadera Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesMadera Biosciences Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsMacular DegenerationBrain Injuries, Traumatic

Other Information

ATC CodeN/A
Related LinksN/A